Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2003
09/04/2003WO2003072719A2 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences
09/04/2003WO2003072704A2 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/04/2003WO2003072595A2 Methods and products based on oligomerization of stress proteins
09/04/2003WO2003072589A1 Novel 15-membered cyclic azalide, novel 16-membered cyclic diazalide derivative, and process for producing these
09/04/2003WO2003072588A1 Macrolides with antibacterial activity
09/04/2003WO2003072582A1 Novel cephalosporin compounds and process for preparing the same
09/04/2003WO2003072576A2 Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them
09/04/2003WO2003072575A1 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
09/04/2003WO2003072574A1 Piperidine ouracil used as a medicament for treating bacterial infections
09/04/2003WO2003072569A1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
09/04/2003WO2003072557A1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
09/04/2003WO2003072553A1 N-aryl-2-oxazolidinone-5-carboxamides and their derivates and their use as antibacterials
09/04/2003WO2003072551A1 Uracil-thioether
09/04/2003WO2003072539A1 Phenethanolamine derivatives for treatment of respiratory diseases
09/04/2003WO2003072141A1 Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride
09/04/2003WO2003072135A2 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
09/04/2003WO2003072120A1 The use of the total coumarins of cnidium monnieri in preparation of the medicament for treating psoriasis
09/04/2003WO2003072117A1 Dialyzed leukocyte extract for the treatment of infectious diseases in animals
09/04/2003WO2003072107A1 Substituted pyrimidinones and pyrimidinthiones
09/04/2003WO2003072094A1 Ambroxol for treating painful conditions in the mouth and pharyngeal cavity
09/04/2003WO2003072027A2 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof
09/04/2003WO2003072016A2 Pharmaceutical compositions in particulate form
09/04/2003WO2003071877A1 Compositions and methods for eliciting an immune response to gram-negative bacterial infections
09/04/2003WO2003064472A3 Treatment of ms with goat serum
09/04/2003WO2003062209A3 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
09/04/2003WO2003051805A3 Substituted phenyl naphthalenes as estrogenic agents
09/04/2003WO2003046560A3 Self-assembly molecules
09/04/2003WO2003037891A8 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
09/04/2003WO2003037304B1 Controlled release compositions for macrolide antimicrobial agents
09/04/2003WO2003037262A3 Novel anit-infectives
09/04/2003WO2003033681A3 Composition comprising a lactobacillus pentosus strain and uses thereof
09/04/2003WO2003029423A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/04/2003WO2003025151A3 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression
09/04/2003WO2002083858A8 Methods to inhibit viral replication
09/04/2003WO2002068058A3 Dapd combination therapy with imdph inhibitors such as ribavirin or mycophenolic acid
09/04/2003WO2002064792A3 Molecules for disease detection and treatment
09/04/2003WO2002060919A3 Molecules with extended half-lives, compositions and uses thereof
09/04/2003WO2002053775A3 Identification of genetic determinants of polymorphic cyp3a5 expression
09/04/2003WO2002052002A3 Immunomodulatory polynucleotides and methods of using the same
09/04/2003WO2002049501A3 Local regional chemotherapy and radiotherapy using in situ hydrogel
09/04/2003WO2002032943A9 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization
09/04/2003WO2002020769A9 Human and mouse targeting peptides identified by phage display
09/04/2003WO2001057261A9 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
09/04/2003WO2000067776A9 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
09/04/2003US20030167502 Human monoclonal antibodies to dendritic cells
09/04/2003US20030166945 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
09/04/2003US20030166922 Antibiotics; therapy for antibiotic resistant infections
09/04/2003US20030166915 Retrovirus from the HIV group and its use
09/04/2003US20030166902 Hybrid; process control; genetic engineering
09/04/2003US20030166849 A peptide of at least 5 amino acids containing a unique portion of a semaphorin, and such peptide has a semaphorin binding specificity
09/04/2003US20030166844 Immunologenic polypeptides; therapy for Streptococcus infections
09/04/2003US20030166832 Methods and compositions for impairing multiplication of HIV-1
09/04/2003US20030166725 Compounds active at the glucocorticoid receptor
09/04/2003US20030166716 Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases
09/04/2003US20030166701 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
09/04/2003US20030166690 Use of compounds for decreasing activity of hormone-sensitive
09/04/2003US20030166689 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
09/04/2003US20030166685 Acid derivatives of benzene useful as anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer
09/04/2003US20030166684 3-phenyl-furan-(5H)-2-one and dihydrofuran-2-one derivatives as antibacterial agents
09/04/2003US20030166671 Amorphous polymorphic forms by grinding or pulverizing; having a distinctive X-ray powder diffraction pattern; anti-tumor and -carcinogenic agents; administered by mouth, intravenous injection and inhalation
09/04/2003US20030166652 Chemical compounds
09/04/2003US20030166646 Nitric oxide synthase inhibitors such as 4-(morpholin-4-yl methyl)-4,5-dihydro-1,3-thiazol-2-ylamine, administered for prophylaxis of neurodegenerative diseases
09/04/2003US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/04/2003US20030166634 Amines such as 3,3,5,5-Tetramethyl-1-vinylcyclohexanamine hydrochloride, used as N-methyl-D-aspartate (NMDA), serotonin and nicotinic acetylcholine receptor antagonists
09/04/2003US20030166630 Amino acid derivatives and their use as medicines
09/04/2003US20030166620 Antibacterial antibiotics; chemical intermediates
09/04/2003US20030166613 A macrocyclic diterpene plant extract for treating viral infections; A computer program product for storing the library information of candidate compounds
09/04/2003US20030166610 Nutritional composition
09/04/2003US20030166588 Splice-region antisense composition and method
09/04/2003US20030166587 Compounds and methods for modulating activation of NF-kB
09/04/2003US20030166585 Substituted tetracycline compounds as synergistic antifungal agents
09/04/2003US20030166569 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
09/04/2003US20030166559 Comprises tumor necrosis factor antagonist activity for treatment of autoimmune conditions
09/04/2003US20030166556 Immunoregulator
09/04/2003US20030166552 For removing viruses from samples (for protection against acquired immunodeficiency syndrome); contraceptives
09/04/2003US20030166546 Uses of THANK, a TNF homologue that activates apoptosis
09/04/2003US20030166545 Compounds and use thereof to modify transport across cell membranes
09/04/2003US20030166537 Use of a gial cell line-derived growth factor (GDNF) or a functionally active derivative or part thereof and/or an agonist which substitutes the functional activity of GDNF, and/ or a nucleic acid containing at least a nucleotide
09/04/2003US20030166535 Preventing lesions of the upper alimentary canal, particularly oral aphthous or mucositis lesions. Intestinal trefoil peptides are administered in effective concentrations either alone or in combination with different therapeutic agents.
09/04/2003US20030166530 Conjugate heat shock protein-binding peptides
09/04/2003US20030166527 Granulocyte colony stimulating factor ("G-CSF") analog polypeptide compositions, related nucleic acids, expression constructs, host cells, and processes for recombinant production of the present G-CSF analogs.
09/04/2003US20030166277 Targeted vaccine delivery systems
09/04/2003US20030166257 Use of Lactobacillus salivarius
09/04/2003US20030166238 Recombinant toxin fragments
09/04/2003US20030166175 Process for clavulanic acid production
09/04/2003US20030166140 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide polyadenylation sequence all
09/04/2003US20030166073 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
09/04/2003US20030166024 Nucleotide sequences coding monoclonal antibody for the prevention, treatment and diagnosis of viral, inflammatory and tumor diseases; gene therapy
09/04/2003US20030165892 Unigene unidirectional antisense library
09/04/2003US20030165889 Identifying and detecting virulence determinant genes of Legionella pneumophila in cells; diagnosing infections
09/04/2003US20030165820 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
09/04/2003US20030165817 Diagnostic assay
09/04/2003US20030165816 Comprises mutant hepatitis B surface antigen for detecting viral diseases; immunoassays; kidney disorders
09/04/2003US20030165814 Screening for sensitivity to mystery swine disease virus infection by transfecting cells with CD antigens; animal husbandry
09/04/2003US20030165569 Composition for topical substance delivery
09/04/2003US20030165561 Substituted diphenyl heterocycles useful for treating HCV infection
09/04/2003US20030165552 Compositions and methods for delivery of skin cosmeceuticals
09/04/2003US20030165540 Sentinel virus II
09/04/2003US20030165537 Vaccination against host cell-associated herpes viruses
09/04/2003US20030165536 Veterinary medicine; vaccine containing mutant gene
1 ... 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 ... 1798